ÀÏ ½Ã |
2019³â 01¿ù 20ÀÏ(ÀÏ) ¿ÀÀü 09 ½Ã 00ºÐ - 16½Ã 00ºÐ |
Àå ¼Ò |
°æÈñ´ëÇб³ Á¾ÇÕ°Àǵ¿(û¿î°ü) ÁöÇÏ 1Ãþ ´ë°´ç |
Program |
Á¦16ȸ °æÈñ½ÅÀå ¿¬¼ö°Á |
Á¦1ºÎ
lgA nephropathy: Past, current and future |
ÁÂÀå: ¹®ÁÖ¿µ(°æÈñ´ë), È«¼ºÇ¥(È«¼ºÇ¥ ³»°ú) |
09:00-09:20 |
Biomarker and precision medicine in lgA nephropathy |
Á¤°æÈ¯(°æÈñ´ë) |
09:20-09:40 |
Recent update of pathology in lgA nephropathy |
¼ºÁö¿¬(°æÈñ´ë) |
09:40-10:00 |
Knowhow to manage the lgA nephropathy patients |
ÀÓõ±Ô(°æÈñ´ë) |
10:00-10:30 |
Coffee Break |
|
Á¦2ºÎ
Real world in management of ESRD patients
|
ÁÂÀå: Á¤°æÈ¯(°æÈñ´ë), ¾ÈÀçÇü(ºÐ´ç¿¸°ÀÇ¿ø) |
10:30-10:50 |
How succefully manage the catheter dysfunction in HD patients? |
ȲÇö¼®(°æÈñ´ë) |
10:50-11:10 |
Paricalcitol, cinacalcet and etelcalcetide: What is difference? |
±è¾ç±Õ(°æÈñ´ë) |
11:10-11:30 |
How to manage the failed graft after kidney transplantation? |
ÀÌÅ¿ø(°æÈñ´ë) |
11:30-12:00 |
ÀÌÅ¿ø, ÀÓõ±Ô ±³¼ö Á¤³â ±â³ä½Ä |
|
12:00-13:00 |
Lunch Time |
|
|
Program |
´ëÇѽÅÀåÇÐȸ »êÇÏ ÀüÇØÁú°íÇ÷¾Ð¿¬±¸È¸ ½ÉÆ÷Áö¾ö |
Á¦1ºÎ
Clinical issues in electrolyte and hypertension |
ÁÂÀå: ÀÌÅ¿ø(°æÈñ´ë), ±è±ÙÈ£(ÇѾç´ë) |
13:00-13:20 |
Dialysate potassium, dialysate magnesium, and hemodialysis risk |
±èÈ¿»ó(¿ï»ê´ë) |
13:20-13:40 |
Ups and downs of dialysate calcium concentration in hemodialysis |
ÀÌ»óÈ£(°æÈñ´ë) |
13:40-14:00 |
Automated blood pressure and CKD progression |
À¯ÅÂÇö(¿¬¼¼´ë) |
14:00-14:20 |
Blood pressure targets for hemodialysis patients |
ÃÖÈ«»ó(Àü³²´ë) |
14:20-14:40 |
Panel discussion °í°Áö(°í·Á´ë), ±è¼¼Áß(¼¿ï´ë), °¼±¿ì(ÀÎÀç´ë), ¹èÀºÈñ(Àü³²´ë) |
|
14:40-15:00 |
Coffee Break |
|
Á¦2ºÎ Interesting and educational cases |
ÁÂÀå:±è¼ö¿Ï(Àü³²´ë), ÃÖ¹ü¼ø(°¡Å縯´ë) |
15:00-15:40 |
Case discussion |
|
15:40-16:00 |
Panel discussion ·ùµ¿¿(ÀÌÈ¿©´ë), À̼ҿµ(Â÷Àǰú´ë), ±è¼º±Õ(ÇѸ²´ë), ±è⼺(Àü³²´ë) |
|